Acute surgical management of proximal humerus fractures: ORIF vs. hemiarthroplasty vs. reverse shoulder arthroplasty

2020 ◽  
Vol 29 (7) ◽  
pp. S32-S40
Author(s):  
B. Israel Yahuaca ◽  
Peter Simon ◽  
Kaitlyn N. Christmas ◽  
Shaan Patel ◽  
R. Allen Gorman ◽  
...  
2020 ◽  
Vol 29 (4) ◽  
pp. e161
Author(s):  
B. Israel Yahuaca ◽  
Shaan Patel ◽  
Kaitlyn N. Christmas ◽  
Peter Simon ◽  
Mark A. Mighell ◽  
...  

2017 ◽  
Vol 26 (10) ◽  
pp. e333
Author(s):  
Bradley S. Schoch ◽  
William R. Aibinder ◽  
Jordan D. Walters ◽  
John W. Sperling ◽  
Thomas (Quin) Throckmorton ◽  
...  

2019 ◽  
Vol 105 (5) ◽  
pp. 805-811 ◽  
Author(s):  
David Gallinet ◽  
Jean-François Cazeneuve ◽  
Etienne Boyer ◽  
Gauthier Menu ◽  
Laurent Obert ◽  
...  

2015 ◽  
Vol 23 (3) ◽  
pp. 190-201 ◽  
Author(s):  
Charles M. Jobin ◽  
Balazs Galdi ◽  
Oke A. Anakwenze ◽  
Christopher S. Ahmad ◽  
William N. Levine

2020 ◽  
Vol 1 (12) ◽  
pp. 731-736
Author(s):  
Timothy Wallace Packer ◽  
Sanjeeve Sabharwal ◽  
Dylan Griffiths ◽  
Peter Reilly

Aims The purpose of this study was to evaluate the cost of reverse shoulder arthroplasty (RSA) for patients with a proximal humerus fracture, using time-driven activity based costing (TDABC), and to compare treatment costs with reimbursement under the Healthcare Resource Groups (HRGs). Methods TDABC analysis based on the principles outlined by Kaplan and a clinical pathway that has previously been validated for this institution was used. Staffing cost, consumables, implants, and overheads were updated to reflect 2019/2020 costs. This was compared with the HRG reimbursements. Results The mean cost of a RSA is £7,007.46 (£6,130.67 to £8,824.67). Implants and staffing costs were the primary cost drivers, with implants (£2,824.80) making up 40% of the costs. Staffing costs made up £1,367.78 (19%) of overall costs. The total tariff, accounting for market force factors and high comorbidities, reimburses £4,629. If maximum cost and minimum reimbursement is applied the losses to the trust are £4,828.67. Conclusion RSA may be an effective and appropriate surgical option in the treatment of proximal humerus fractures; however, a cost analysis at our centre has demonstrated the financial burden of this surgery. Given its increasing use in trauma, there is a need to work towards generating an HRG that adequately reimburses providers. Cite this article: Bone Jt Open 2020;1-12:731–736.


Sign in / Sign up

Export Citation Format

Share Document